Phase 2 feasibility study of adjuvant chemotherapy with cisplatin (CDDP) and TS-1, followed by alternate-day TS-1 maintenance therapy, in patients with completely resected pathological stage II-IIIA non-small cell lung cancer.
- DOI
- 10.21037/jtd-2025-1518
- Published
- 2025 Nov 30
- Container
- Journal of thoracic disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21037/jtd-2025-1518,
title = {Phase 2 feasibility study of adjuvant chemotherapy with cisplatin (CDDP) and TS-1, followed by alternate-day TS-1 maintenance therapy, in patients with completely resected pathological stage II-IIIA non-small cell lung cancer.},
author = {Fujino K and Maruyama R and Marutsuka T and Iwatani K and Aoki M and Suetsugu T and Takenaka M and Saeki S and Sakata S and Motooka Y and Masuda Y and Yoshimoto K and Ikeda K and Suzuki M},
year = {2025},
journal = {Journal of thoracic disease},
doi = {10.21037/jtd-2025-1518},
url = {https://doi.org/10.21037/jtd-2025-1518}
}RIS
TY - JOUR TI - Phase 2 feasibility study of adjuvant chemotherapy with cisplatin (CDDP) and TS-1, followed by alternate-day TS-1 maintenance therapy, in patients with completely resected pathological stage II-IIIA non-small cell lung cancer. AU - Fujino K AU - Maruyama R AU - Marutsuka T AU - Iwatani K AU - Aoki M AU - Suetsugu T AU - Takenaka M AU - Saeki S AU - Sakata S AU - Motooka Y AU - Masuda Y AU - Yoshimoto K AU - Ikeda K AU - Suzuki M PY - 2025 JO - Journal of thoracic disease DO - 10.21037/jtd-2025-1518 UR - https://doi.org/10.21037/jtd-2025-1518 ER -
APA
K, F., R, M., T, M., K, I., M, A., T, S., M, T., S, S., S, S., Y, M., Y, M., K, Y., K, I., & M, S. (2025). Phase 2 feasibility study of adjuvant chemotherapy with cisplatin (CDDP) and TS-1, followed by alternate-day TS-1 maintenance therapy, in patients with completely resected pathological stage II-IIIA non-small cell lung cancer.. Journal of thoracic disease. https://doi.org/10.21037/jtd-2025-1518
Source records
- pubmed · retrieved 2026-09-25T11:33:55.134Z